Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Jingyuan Biotechnology is a specialized biochemical manufacturer based in Heze, China, focusing on the production of animal-derived active pharmaceutical ingredients (APIs). The company is a major supplier of Heparin Sodium and its low molecular weight derivatives, such as Enoxaparin and Dalteparin, which are critical for anticoagulant therapies. Additionally, they produce Chondroitin Sulfate for use in joint health supplements and pharmaceuticals. Shandong Jingyuan operates GMP-certified facilities and exports its products to various global markets, positioning itself as a key player in the heparin value chain. Their expertise lies in the large-scale extraction and purification of complex polysaccharides from porcine sources. The company supports the global pharmaceutical industry by providing high-purity raw materials for life-saving medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Jingyuan.